KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Market Cap	$190.03M	P/E Ratio	N/A
52W High	$6.11	52W Low	$1.86
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-9.1%	52W Position	92.2%
Overall Score	62	Value Score	40
Quality Score	65	Technical Score	81

EPS Current Est	$-0.06	EPS Next Est	$-0.01
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	KRMD	$5.78	-1.37%	124.71K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	KRMD	$5.78	-1.4%	124.71K
3
4
5
6

KRMD

KRMD

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get KORU Medical Systems Inc. Data in Excel

Get KORU Medical Systems Inc. Data in Excel